NCT00352235View on ClinicalTrials.gov

Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

May 31, 2005

Conditions
Chronic Hepatitis C
Interventions
DRUG

KRN7000

Trial Locations (1)

3000CA

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Kyowa Kirin Co., Ltd.

INDUSTRY

lead

Foundation for Liver Research

OTHER